Abstract
COVID-19 pandemic is an enigma with uncertainty caused by multiple biological and health systems factors. Although many models have been developed all around the world, transparent models that allow interacting with the assumptions will become more important as we test various strategies for lockdown, testing and social interventions and enable effective policy decisions. In this paper, we developed a suite of models to guide the development of policies under different scenarios when the lockdown opens. These had been deployed to create an interactive dashboard called COVision which includes the Agent-based Models (ABM) and classical compartmental models (CCM). Our tool allows simulation of scenarios by changing the strength of lockdown, basic reproduction number(R0), asymptomatic spread, testing rate, contact rate, recovery rate, incubation period, leakage in lockdown etc. We optimized ABM and CCMs and evaluated them on multiple error metrics. Out of these models in our suite, ABM was able to capture the data better than CCMs. Our evaluation suggests that ABM models were able to capture the dynamic nature of the epidemic for a longer duration of time while CCMs performed inefficiently. We computed R0 using CCMs which were found to be decreasing with lockdown duration, indicating the effectiveness of policies in different states of India. Models have been deployed on a dashboard hosted at http://covision.tavlab.iiitd.edu.in which allows users to simulate outcomes under different parameters and will allow the policymakers to make informed decisions and efficient monitoring of the covid19 pandemic in India.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially supported by the Wellcome Trust/DBT India Alliance Fellowship IA/CPHE/14/1/501504 awarded to Tavpritesh Sethi and the Center for Artificial Intelligence at IIIT-Delhi. We also thank CSIR India for supporting Aditya Nagori and UGC India for supporting Raghav Awasthi. We acknowledge Rakesh Lodha from All India Institute of Medical Sciences, New Delhi, for his valuable inputs and Bhavika Rana for her design input for the dashboard frontend.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research did not involve human participants. Publicly available statistics were used to train the models.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data were used in the manuscript are publicly available from the Ministry of Health and Family Welfare, Government of India website.
